TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.

Roisin M Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.